1
项与 MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital) 相关的临床试验Phase 1 Study of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors
The purpose of this study is to evaluate the clinical safety and preliminary efficacy of MAGE-A4 TCR Gene-Modified T lymphocytes in the treatment of malignant solid tumor patients, such as malignant melanoma and lung cancer.
100 项与 MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital) 相关的临床结果
100 项与 MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital) 相关的转化医学
100 项与 MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital) 相关的专利（医药）
100 项与 MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital) 相关的药物交易
